Pregnant People-Infant Linked Longitudinal Surveillance

CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO) DD23-2303, Mother-Infant Linked Longitudinal Surveillance.

The project period will be four years, with 4 12-month budget periods and an anticipated project start date of September 1, 202 3. The purpose of this NOFO

credit: Flickr


is to conduct mother-infant linked longitudinal surveillance on key exposures and outcomes of public health interest through both a clinic- and health department-based approach.

These approaches collect health information from various sources and/or conduct data linkages, resulting in robust data across multiple years from pregnancy into childhood.

The cooperative agreement intends to sustain, improve, and expand surveillance efforts from clinical sites and health departments related to mother-infant linked longitudinal data to ensure timely reporting of key exposures and outcomes that impact pregnant people and infants, to improve data quality and share evolving outcome data, to innovate clinical strategies, and build a strong collaborative network.

Priority exposures and outcomes of public health interest may include, but not limited to medication for opioid use disorder, neonatal abstinence syndrome, cytomegalovirus, stillbirths (not intended to be longitudinal), and other conditions that may have serious impacts on pregnant people and infants.

Strategic areas of focus may include advancing interoperability, data quality and informatics, and innovating and strengthening public health reporting.

Focus areas may also include monitoring maternal, infant, and child outcomes including follow-up for diverse clinical and neurodevelopmental outcomes of children exposed to infectious and non-infectious threats that are not currently national notifiable.
Related Programs

Birth Defects and Developmental Disabilities - Prevention and Surveillance

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Centers for Disease Control - NCBDDD

Estimated Funding: $5,000,000


Who's Eligible





Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html

Additional Information of Eligibility:
Eligible applicants must have the public health authority, legislative mandate or otherwise show legal access to the requisite data to conduct clinic or population-based surveillance.

This authority allows unique and specific access to datasets from multiple data sources that are required to implement the activities outlined in this NOFO.

This may be an MOU, letter of support, or other legal documentation to demonstrate public health authority, legislative mandate, or legal access to the data.

Eligible applicants must document this authority in "Other Attachment Forms" with attachment name "Legal Authority" as a PDF uploaded to www.grants.gov.

CDC will consider any application that does not include this required documentation as non-responsive, and it will receive no further review.    A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.

If applying as a Bona Fide Agent of a state government, a letter from the state government as documentation of the status is required and should be submitted under "Other Attachment Forms" with attachment name "Bona Fide Agent.” If the Bona Fide Agent attachment does not specify legal authority, the applicant must include an attachment named "Legal Authority" in "Other Attachment Forms".    The NOFO has three components: A, B, and C.

Eligible applicants may only apply for Component A, Component B, or Component C.

If an applicant submits multiple applications, all applications will be deemed non-responsive, and none will receive further review.

In the “Descriptive Title of Applicant’s Project” on the SF-424 form, applicants must identify the component to which they are applying. 

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html

Contact:


Agency Email Description:
preg_infant_surv@cdc.gov

Agency Email:


Date Posted:
2023-02-09

Application Due Date:


Archive Date:
2023-05-10


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


Training in General, Pediatric, and Public Health Dentistry | Mortgage Insurance_Homes | Safe Kids Worldwide | Criminal and Juvenile Justice and Mental Health Collaboration Program | Overseas Programs Doctoral Dissertation Research Abroad |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders